Furthermore, in the case of KRASG12D in CRC [159] or KRASG12V in PDAC [160], the upregulation of MEK/ERK/IL-10 and MEK/ERK/TGF-β promoted the Tregs differentiation and inhibited T cell activation. This evidence concerns the gene TGFB1 and colorectal carcinoma.